HCW Biologics Inc.

NASDAQ:HCWB

6.9 (USD) • At close April 25, 2025
Bedrijfsnaam HCW Biologics Inc.
Symbool HCWB
Munteenheid USD
Prijs 6.9
Beurswaarde 7,751,115
Dividendpercentage 0%
52-weken bereik 6.825 - 100.8
Industrie Biotechnology
Sector Healthcare
CEO Dr. Hing C. Wong Ph.D.
Website https://www.hcwbiologics.com

An error occurred while fetching data.

Over HCW Biologics Inc.

HCW Biologics Inc., a preclinical stage biopharmaceutical company, focuses on discovering and developing novel immunotherapies for chronic, low-grade inflammation, and age-related diseases. The company's lead products include HCW9218, which is an injectable immunotherapeutic for patients with pancreatic, ovarian, breast, prostate, and colorectal cancers, as well as pulmonary fibrosis; and HCW9302

Vergelijkbare Aandelen

Anebulo Pharmaceuticals, Inc. logo

Anebulo Pharmaceuticals, Inc.

ANEB

1.14 USD

Minerva Surgical, Inc. logo

Minerva Surgical, Inc.

UTRS

0 USD

TScan Therapeutics, Inc. logo

TScan Therapeutics, Inc.

TCRX

1.6 USD

Galectin Therapeutics Inc. logo

Galectin Therapeutics Inc.

GALT

1.32 USD

Eyenovia, Inc. logo

Eyenovia, Inc.

EYEN

1.09 USD

Centogene N.V. logo

Centogene N.V.

CNTG

0.325 USD

Augmedix, Inc. logo

Augmedix, Inc.

AUGX

2.345 USD

Viracta Therapeutics, Inc. logo

Viracta Therapeutics, Inc.

VIRX

0.022 USD

Financiële Gegevens

Cijfers zijn in miljoenen (USD)

Cijfers zijn in miljoenen (USD)